Anthony Doyle

Anthony Doyle, Chief Financial Officer (CFO) at Flourish Research, has more than 20 years of leadership experience in the life sciences industry. In this role, Anthony oversees Flourish’s financial strategy and operations, with a focus on driving sustainable growth and operational excellence in the clinical research space. 

Before joining Flourish, Anthony served as CFO at BioCryst Pharmaceuticals (Nasdaq: BCRX), where he led the company through a transformational growth phase—from a clinical stage biotech to a global rare disease leader with almost $500M in revenue and a $2B+ market cap. During his tenure, BioCryst raised over $1B in capital and achieved operational profitability and capital market independence. 

Prior to those roles, he held a broad array of financial positions of increasing responsibility at Worldwide Clinical Trials, World Book (A Berkshire Hathaway company), and General Electric where he graduated from their acclaimed Financial Management and Corporate Audit Staff Programs.  

Named one of the Top 25 Biotech CFOs of 2024, Anthony is passionate about unlocking business potential through data insights and data-driven decision-making, while empowering teams to achieve extraordinary success, and is privileged to do this in an industry focused on improving patient outcomes.